Compare CBUS & BGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CBUS | BGX |
|---|---|---|
| Founded | 2010 | N/A |
| Country | United States | United States |
| Employees | 118 | N/A |
| Industry | Agricultural Chemicals | Trusts Except Educational Religious and Charitable |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.2M | 136.6M |
| IPO Year | 2017 | 2010 |
| Metric | CBUS | BGX |
|---|---|---|
| Price | $1.51 | $10.55 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 89.2K | 67.6K |
| Earning Date | 05-14-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 74.33 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,639,000.00 | N/A |
| Revenue This Year | $112.72 | N/A |
| Revenue Next Year | $83.18 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.09 | $10.38 |
| 52 Week High | $4.19 | $12.04 |
| Indicator | CBUS | BGX |
|---|---|---|
| Relative Strength Index (RSI) | 38.83 | 36.61 |
| Support Level | $1.22 | $10.42 |
| Resistance Level | $1.60 | $10.94 |
| Average True Range (ATR) | 0.10 | 0.07 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 28.07 | 26.01 |
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
Blackstone Long-Short Credit Income Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income, with a secondary objective to seek preservation of capital, consistent with its primary goal of high current income. The company's seeks to achieve its investment objectives by employing a dynamic long-short strategies in a diversified portfolio of loans and fixed-income instruments of predominantly U.S. corporate issuers, including first and second-lien secured loans (Secured Loans) and high-yield corporate bonds of varying maturities.